Election Win by Houston RNs Upheld ( Vote Affirmed for Nation...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Election Win by Houston RNs Upheld

Date:5/6/2008

Vote Affirmed for Nation's Largest RN Organization

First Texas Hospital where RNs win Union Representation

HOUSTON, May 6 /PRNewswire/ -- Registered nurses at Cypress Fairbanks Medical Center Hospital in Houston have won for a second time in their campaign to affiliate with NNOC Texas -- Texas affiliate of the National Nurses Organizing Committee/California Nurses Association, the largest and fastest growing organization of RNs in the nation.

A neutral third party arbitrator today overruled all objections filed by hospital administrators to the election win by the RNs in late March. The decision by arbitrator Diane Dunham Massey, which is final and binding, affirms Cypress Fairbanks as the first hospital in Texas where RNs have won union representation.

NNOC Texas will represent nearly 300 RNs at the hospital, and the RNs have already begun work to negotiate their first ever collective bargaining contract to enhance standards for their patients and themselves, said NNOC/CNA in a statement today.

"We are extremely gratified that the democratic vote of the Cypress Fairbanks nurses has been protected, and their voices upheld. This is another banner day for Texas RNs and patients," said NNOC/CNA Executive Director Rose Ann DeMoro.

"We nurses are pleased that these allegations have been overturned. We hope that the hospital turns the page, and we look forward to negotiating a great contract where we achieve a stronger voice for patient care," said Keith Merritt, an emergency room RN at Cypress Fairbanks.

"Today's decision validates the victory of Cypress Fairbanks RNs in their historic election on March 28," said NNOC/CNA organizing director David Johnson.

"This decision means that Cypress Fairbanks RNs can immediately begin to negotiate dramatic improvements in their conditions, and to build a strong RN union that will serve as a beacon to thousands of other Texas RNs. Their victory is celebrat
'/>"/>

SOURCE National Nurses Organizing Committee/California NursesAssociation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
2. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Stater Bros. Introduces New Healthy Selections Dietitian Program
6. Humor and Hope Sustain NJ Woman Through Disabling Movement Disorder, Election Campaign
7. Healthcare Workers to St. Joseph Health System: Fair Election Agreement Now
8. HealthTek Software Solutions Licenses First DataBanks OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation
9. Healthcare Workers, Community Activists Call for Fair Election Agreement at St. Joseph Health System
10. Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
11. Whittier Hospital RNs Choose CNA/NNOC in Landslide 87% Election Victory

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting 2 Health News:Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health 2 Health News:Molecule Discovery Might Help ALS Patients 2 Health News:Swine Flu Has Infected 1 in 6 Americans: CDC 2 Health News:Swine Flu Has Infected 1 in 6 Americans: CDC 3 Health News:Macomb County Announces New Location for Four Upcoming H1N1 Clinics 2

[1] Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting [0] Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health [0] Molecule Discovery Might Help ALS Patients [0] Swine Flu Has Infected 1 in 6 Americans: CDC [0] Macomb County Announces New Location for Four Upcoming H1N1 Clinics

Priligy(TM) (Dapoxetine) Receives First Regulatory Approvals for the Treatment of Premature Ejaculation (PE) in Finland and Sweden Garry W. Rogerson Elected Chairman of the Board of Varian, Inc.Smokers Will Stop for Their Pet's Sake Diseased Heart Valve Replaced Through Small Chest Incision The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders Shaklee Hits the Road with its Infinite Possibilities Tour in New York, NY

Breaking Medicine Technology:ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3 Within3 Expands into Mobile Applications 2 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 1 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 2 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 3 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 4 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 5 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 1 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 2 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 3 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 4 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 5 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 6 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 1 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 2 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 3 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 4

[0] ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)[0] Boston Scientific Announces Pricing of $2 Billion of Senior Notes [0] Within3 Expands into Mobile Applications

Other Medicine Technology:Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 2 Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 3 Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis 2

Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis

Medicine Products:

Hydrophobic Tubing Filter (green-tinted PVC)Clear-Therm Mini™ + Micro Mount with Flextube Clear-Therm®Filta-Therm® with CO₂ Port

Election Win by Houston RNs Upheld( Vote Affirmed for Nation...),Health